Patents Assigned to Catalyst Pharmaceutical Partners
  • Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid
    Patent number: 8969413
    Abstract: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 or its pharmaceutically acceptable salts can be used to treat addiction and neurological disorders such as epilepsy without side effects such as visual field defects caused by vigabatrin (Sabril).
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: March 3, 2015
    Assignees: Catalyst Pharmaceutical Partners, Brookhaven Science Associates, Northwestern University
    Inventors: Richard B. Silverman, Stephen L. Dewey, Steven Miller